Lee Ainslie - Maverick Capital
Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2021 Q2 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2021 Q1 | 2,711 | 0.00 | Reduce 82.12% | 0.00 | $41.68 |
| 2020 Q4 | 15,164 | 0.01 | Buy | 0.01 | $42.73 |